Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarkers for Risk Stratification in Lung Cancer — Stella

Home/Nodule Solitary Pulmonary/Biomarkers for Risk Stratification in Lung Cancer

View on ClinicalTrials.gov

Recruiting

Back to Nodule Solitary Pulmonary trials

Biomarkers for Risk Stratification in Lung Cancer

Trial locations(3 sites)

United States

Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California

San Francisco VA Medical Center, San Francisco, California

University of California, San Francisco, San Francisco, California

Key details

Sponsor

University of California, San Francisco

Collaborators

Northern California Institute of Research and Education, Guardant Health, Inc.

Enrollment target

~590 participants

Started

December 2017

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

40 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.